J Obes Metab Syndr.  2021 Sep;30(3):209-221. 10.7570/jomes21043.

Unravelling Polycystic Ovary Syndrome and Its Comorbidities

• Kim KW

• KMID: 2521070
• DOI: http://doi.org/10.7570/jomes21043

Abstract

Polycystic ovary syndrome (PCOS) is a chronic multisystem endocrine disorder that affects women of reproductive age. In the ovary, the dynamic balance between dormant and growing follicles that culminates in ovulation becomes dysfunctional in the presence of excessive androgen production (ovarian/adrenal/peripheral). Moreover, hyperandrogenicity in pregnancy affects fetal development in utero and is linked to maternal pregnancy complications. Hormonal imbalance, ovarian dysfunction, and central obesity often emerge in these patients during adolescence. Once disordered physiological changes develop in PCOS, a vicious cycle ensues, leading to reproductive, metabolic, and psychological comorbidities. With the alarming increase of the number of young adults with a high degree of obesity in Korea, the prevalence of PCOS has also considerably increased. Timely and accurate screening, multicomponent healthy lifestyle modifications for both patients and family members, and comprehensive medical interventions based on international evidence-based guidelines are essential for curtailing PCOS and its comorbidities.

Keyword

Polycystic ovary syndrome; Androgens; Adrenal gland; Insulin resistance; Anti-Müllerian hormone